Chizaram A. Onyeaghala

Dr. Chizaram A. Onyeaghala

Internal Medicine, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2025 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
AEAdaeze E. Egwudo
Adaeze E. Egwudo
Ayodapo JegedeAyodapo Jegede
Ayodapo Jegede
TOTolulope A. Oyeniyi
Tolulope A. Oyeniyi
NENkolika Jacinta Ezekwelu
Nkolika Jacinta Ezekwelu
SASamirah N. Abdu-Aguye
Samirah N. Abdu-Aguye
OSOlajide Odunayo Sobande
Olajide Odunayo Sobande
Integrating digital health technologies (DHTs) in Nigeria’s healthcare system holds promise, yet the opportunities, challenges, and strategies influencing their success remain insufficiently explored. This scoping review aimed to map these factors, focusing on healthcare settings in Nigeria. A comprehensive search of databases (PubMed, Scopus, Web of Science, and CINAHL) and Google Scholar identified publications on DHT use in Nigeria from July 1, 2014, to June 30, 2024. A total of 31 observational and experimental studies were included involving healthcare workers, patients, caregivers, or other stakeholders impacted by DHT integration. Key findings revealed that DHTs enhanced treatment adherence, healthcare utilization, and community engagement while expanding technology infrastructure for scaling interventions. Notable opportunities included support and training and improved data quality. However, challenges such as operational and logistical barriers, inadequate network coverage, and cultural and gender sensitivity issues were prevalent. Strategies to address these challenges focused on continuous training for healthcare workers, community involvement to foster engagement, and data reporting and quality improvements. Despite their potential to transform healthcare delivery, particularly in underserved areas, successful integration of DHTs in Nigeria requires addressing infrastructure gaps, cultural norms, and operational challenges. Community engagement, capacity building for healthcare workers, and data-driven decision-making are critical to maximizing the impact of digital health interventions in Nigeria.

7 December 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
JMJuliet I Mmerem
Juliet I Mmerem
CUChukwudi C Umenzekwe
Chukwudi C Umenzekwe
SJSimon M Johnson
Simon M Johnson
AOAsukwo E Onukak
Asukwo E Onukak
NCNneka M Chika-Igwenyi
Nneka M Chika-Igwenyi
KCKyrian S Chukwu
Kyrian S Chukwu
Background: We describe clinicoepidemiologic characteristics of mpox-chickenpox coinfection in Nigeria. Methods: A retrospective cohort analysis was performed of confirmed mpox cases in Nigeria from January 2022 to March 2023. Mpox and chickenpox were confirmed by real-time polymerase chain reaction (RT-PCR). Results: Of 94 (60.0%) suspected cases, 56 had confirmed mpox, of whom 16 (28.6%) had chickenpox coinfection. The median age of confirmed mpox cases was 29 years (interquartile range, 20–37 years), 24 were men (60.7%), 6 (10.7%) were bisexual, and 5 (8.9%) died. Mpox-chickenpox–coinfected patients had more complications than mpox-monoinfected cases (56.3% vs 22.5%, P = .015). Conclusions: The high frequency of mpox-chickenpox coinfection argues for accelerated access to mpox and chickenpox vaccines in Africa.

10 May 2025 in Discover Public Health
Verified
Journal Article
Open access
PDF file
Yousra El-MaradnyYousra El-Maradny
Yousra El-Maradny
MNMark Anum Nortey
Mark Anum Nortey
CHCLYDE HAKAYUWA
CLYDE HAKAYUWA
EAEbuka Louis Anyamene
Ebuka Louis Anyamene
JMJ. Jenifer Florence Mary
J. Jenifer Florence Mary
MEMajani Edward
Majani Edward
The issue of antimicrobial resistance (AMR) is of global significance, affecting both developed and underdeveloped nations. In the context of low- and middle-income countries (LMICs), in Africa and other regions confronted with worsening health inequities such as inadequate healthcare resources and infrastructure, and a rising burden of infectious diseases, the adverse impact of antimicrobial resistance is exacerbated. This narrative review delves into the difficulties encountered in tackling the effects of AMR, focusing specifically on LMICs in Africa, where the overlap of climatic factors, socio-economic disparities, and inequities in access to healthcare intensifies the problem. The themes that emerged from the review include the need for infection prevention and control strategies, the adoption of a One Health approach to combat AMR, and the need for surveillance and monitoring. Several challenges were identified, including organizational and governmental issues, and the absence of leadership commitment. The review also emphasized the need for public and professional education for healthcare professionals and patients to promote and influence behavioral change patterns, a central aspect of AMR issues in Africa. These initiatives should be in tandem with enhanced diagnostic capacity, effective AMR surveillance, and capacity building at all levels of the healthcare system. Sustaining antimicrobial stewardship programs in Africa presents considerable obstacles, ranging from financial constraints to the lack of political will and coordinated efforts. When countries and partners adequately address these challenges by implementing sustainable solutions, LMICs in Africa can mitigate the threat of AMR, safeguard public health, and promote the responsible use of antimicrobials for future generations.

17 December 2024 in Infection Ecology & Epidemiology
Verified
Journal Article
Open access
MEMajani Edward
Majani Edward
AHAmira M. Heniedy
Amira M. Heniedy
ASAbdullahi Saminu
Abdullahi Saminu
JMJ. Jenifer Florence Mary
J. Jenifer Florence Mary
DADuaa A. Ahmed
Duaa A. Ahmed
Safieh ShahSafieh Shah
Safieh Shah
This article investigates the escalating occurrence of zoonotic diseases in Africa, attributing their spread to climate change and human activities. Africa’s unique combination of biodiversity, reliance on animal husbandry, and swift urbanization heightens its susceptibility. Climate change disrupts ecosystems and animal habitats, intensifying human-wildlife interactions. Urbanization, inadequate sanitation, and insufficient healthcare infrastructure further facilitate disease spread. Climate-induced displacement adds another layer of complexity. Mitigation strategies include improving surveillance systems, fostering early detection via point-of-care diagnostics and digital contact tracing, and investing in vaccines and therapeutics. Our purpose of this is to advocate for sustainable land use, robust community-level public health systems, international cooperation, and resource-sharing. We also emphasize the need for effective vector-control policies, dedicated research funding, and annual awareness, vaccination, and early detection campaigns in endemic regions.

3 March 2025 in Pan African Medical Journal
Verified
Journal Article
Open access
COChizaram A. Onyeaghala
Chizaram A. Onyeaghala
ASAbiye Somiari
Abiye Somiari
UIUjile Ichechiek
Ujile Ichechiek
JOJohn Ogan
John Ogan
HAHope Avundaa
Hope Avundaa
DADatonye Alasia
Datonye Alasia
Introduction: limited studies describe the epidemiology, clinical presentation, and outcome of mpox in Rivers State, Nigeria. Methods: an observational retrospective study of suspected mpox cases seen between October 21, 2021, and April 30, 2023, at the University of Port Harcourt Teaching Hospital, Rivers State, Nigeria. Laboratory confirmation was by qPCR testing of skin swabs, or crust samples. A data extraction form was used to obtain sociodemographic and clinical data. The primary outcome was the rate of hospitalization and death. Data was analyzed using IBM SPSS version 25. A p-value of <0.05 was considered statistically significant. Results: of 35 participants, 24 (68.6%) were males with a mean age [standard deviation] of 33.7 (± 9.9 years), and 5 (14.3%) had HIV infection. The majority (n=33, 94.3%) reported being in a heterosexual relationship with a household identified as the probable place of contact (n=13, 72.2%). None of the patients reported contact with animals or a travel history. The most common symptoms were skin rash (35, 100%), followed by fever (26, 74.3%), and fatigue (26, 74.3%). Concomitant varicella zoster virus infection (n=6, 17.1%), hospital admission (n=28, 80%), and death (n=3, 8.6%) were observed. There was a statistically significant association between mortality and patients with HIV (p = 0.002). Conclusion: the 2022-23 mpox outbreak in Rivers State predominantly affected young adults and was characterized by human-to-human transmission and typical febrile rash syndrome with an association between mpox mortality and HIV infection. Targeted public health interventions are needed to control the spread of mpox in Nigeria.

1 April 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
COChizaram A. Onyeaghala
Chizaram A. Onyeaghala
DADatonye Alasia
Datonye Alasia
OEOrezioghene Eyaru
Orezioghene Eyaru
NPNsirimobu Paul
Nsirimobu Paul
OMOmosivie Maduka
Omosivie Maduka
EEEmeka Eyidia
Emeka Eyidia
Most reports of Multisystem Inflammatory Syndrome (MIS-C) have come from Europe and North America. The paucity of reports in Africa is in contrast with the demographics of the series in New York, Paris and UK with children of African ancestry accounting for over 40% of all cases of MIS-C. With the global trend of higher prevalence of MIS-C in children of African ancestry, enhanced surveillance and awareness for this syndrome in children with COVID-19 in Africa are therefore important. A case report of a 12-year-old Nigerian girl with MIS-C is presented in line with the WHO global surveillance especially in areas were MIS-C is considered a rarity. This case report stimulates a call for vigilance and expanded effort at surveillance to promote early recognition and diagnosis of MIS-C in Nigeria and Africa. The favourable outcome and experience from this case will create awareness, expand knowledge, and support clinicians in Nigeria and the African continent in their approach to other potential cases.